Abstract
Caseins cross-reactivity rises up to 90% between cow’s milk (CM) and other bovid milks. There are few studies on tolerance to other mammals milk in patients submitted to cow’s milk oral immunotherapy (CMOIT). AIMS: To determine the percentage of patients whom after CMOIT tolerate water buffalo (WB), goat and sheep’s milk proteins (MP). To describe immunologic features which can predict allergy.
Highlights
PD28 - Is other bovid mammals milk tolerated by children who have been submitted to cow’s milk oral immunotherapy?
Caseins cross-reactivity rises up to 90% between cow’s milk (CM) and other bovid milks
Inclusion criteria: children submitted to cow’s milk oral immunotherapy (CMOIT) tolerating >150cc CM daily, more than 1 year in maintenance phase
Summary
PD28 - Is other bovid mammals milk tolerated by children who have been submitted to cow’s milk oral immunotherapy?. Mònica Piquer Gibert*, Spera Adriana Machinena, Montserrat Alvaro Lozano, Maria Teresa Giner Muñoz, Olga Domínguez Sánchez, Jaime Lozano Blasco, Ana Maria Plaza Martin. From 3rd Pediatric Allergy and Asthma Meeting (PAAM) Athens, Greece. From 3rd Pediatric Allergy and Asthma Meeting (PAAM) Athens, Greece. 17-19 October 2013
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
